Compile Data Set for Download or QSAR
maximum 50k data
Found 91 of ph data with Target = 'Potassium voltage-gated channel subfamily H member 2'
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM237161(US9402878, II)
Affinity DataIC50: >1.00E+5nMpH: 7.0Assay Description:Briefly, the experiments were performed on an IonWorks™ HT instrument (Molecular Devices Corporation), which automatically performs electrophys...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM50121975((6-Methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2...)
Affinity DataIC50:  1.44E+3nMpH: 7.0Assay Description:Briefly, the experiments were performed on an IonWorks™ HT instrument (Molecular Devices Corporation), which automatically performs electrophys...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291377(4-[1-(4-Chlorophenyl)-2-(1-methyl-1H-pyrazol-5-yl)...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291387(4-[1-(4-Chlorophenyl)-2-(2H-1,2,3,4-tetrazol-5-yl)...)
Affinity DataIC50: >1.00E+4nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291385(US9580415, Example 19 | {[1-(4-Chlorophenyl)-2-(py...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291384(5-[1-(4-Chlorophenyl)-3-(piperidin-4-yl)-1H-pyrrol...)
Affinity DataIC50: >1.00E+4nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291383(4-[1-(4-Chlorophenyl)-3-(piperidin-4-yl)-1H-pyrrol...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291380(4-[1-(4-Chlorophenyl)-2-(1H- imidazol-1-yl)-1H-pyr...)
Affinity DataIC50: >1.00E+4nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291379(4-[1-(4-Chlorophenyl)-2-(1H- pyrazol-1-yl)-1H-pyrr...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291378(4-[1-(4-Chlorophenyl)-2-(1- methyl-1H-imidazol-5-y...)
Affinity DataIC50: >1.00E+4nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291375(4-[1-(4-Chlorophenyl)-2-(1H- pyrazo1-4-yl)-1H-pyrr...)
Affinity DataIC50: >1.00E+4nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291374(4-[1-(4-Chlorophenyl)-2-(1H- pyrazol-3-yl)-1H-pyrr...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291373(4-[1-(4-Chlorophenyl)-2- (pyrimidin-5-yl)-1H-pyrro...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291372(4-[1-(4-Chlorophenyl)-2-[6- (morpholin-4-yl)pyridi...)
Affinity DataIC50:  550nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291370(4-[1-(4-Chlorophenyl)-2-(2- methoxypyridin-4-yl)-1...)
Affinity DataIC50:  550nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291368(4-[1-(4-Chlorophenyl)-2- (pyridin-3-yl)-1H-pyrrolo...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM291367(4-[2-(6-Aminopyridin-3-yl)-1-(4-chlorophenyl)-1H-p...)
Affinity DataIC50:  5.50E+3nMpH: 7.3 T: 2°CAssay Description:Compounds of the invention were tested for inhibition of the human ether a go-go related gene (hERG) K+ channel using IonWorks patch clamp electrophy...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287604(US10420768, Compound C-175 | US11752155, Compound ...)
Affinity DataIC50:  4.50E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287597(US10420768, Compound C-128 | US11752155, Compound ...)
Affinity DataIC50:  2.80E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287596(US10420768, Compound C-127 | US11752155, Compound ...)
Affinity DataIC50:  6.00E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287594(US10420768, Compound C-230 | US11752155, Compound ...)
Affinity DataIC50:  1.38E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287589(US10420768, Compound C-5 | US11752155, Compound C-...)
Affinity DataIC50:  9.50E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287588(US10420768, Compound C-4 | US11752155, Compound C-...)
Affinity DataIC50:  1.14E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280739(US10030026, Compound LX-1 | US10221182, Compound L...)
Affinity DataIC50:  4.50E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280739(US10030026, Compound LX-1 | US10221182, Compound L...)
Affinity DataIC50:  4.50E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280737(US10030026, Compound C-127)
Affinity DataIC50:  2.30E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280736(US10030026, Compound C-33)
Affinity DataIC50: >3.00E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280734(US10030026, Compound C-18)
Affinity DataIC50:  1.20E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280732(US10030026, Compound C-16)
Affinity DataIC50:  1.30E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM280726(US10030026, Compound C-5)
Affinity DataIC50:  3.10E+4nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM287587(US10420768, Compound C-3 | US11752155, Compound C-...)
Affinity DataIC50:  7.00E+3nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24054((2S)-4-(2,5-difluorophenyl)-N-methyl-2-phenyl-N-(p...)
Affinity DataIC50:  1.30E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24055((2S)-4-(2,5-difluorophenyl)-N-(1-acetylpiperidin-4...)
Affinity DataIC50: >1.00E+4nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24056((2S)-N-(3-aminopropyl)-4-(2,5-difluorophenyl)-N-me...)
Affinity DataIC50:  1.30E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24057(3-amino-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,...)
Affinity DataIC50:  2.20E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24058((2S)-2-amino-1-[(2S)-4-(2,5-difluorophenyl)-2-phen...)
Affinity DataIC50:  2.40E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24060((2S)-2-amino-2-cyclopropyl-1-[(2S)-4-(2,5-difluoro...)
Affinity DataIC50:  3.50E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24061((2S)-2-amino-1-[(2S)-4-(2,5-difluorophenyl)-2-phen...)
Affinity DataIC50:  1.50E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24062(2-hydroxyethyl N-[(2S)-1-[(2S)-4-(2,5-difluorophen...)
Affinity DataIC50:  2.50E+4nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24063((2S)-2-cyclopropyl-1-[(2S)-4-(2,5-difluorophenyl)-...)
Affinity DataIC50:  1.10E+4nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24065(1-[(5S)-3-(2,5-difluorophenyl)-5-(3-hydroxyphenyl)...)
Affinity DataIC50:  26.4nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24089((5S)-5-(3-aminopropyl)-3-(2,5-difluorophenyl)-N,N-...)
Affinity DataIC50:  19.3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24103(1,4-diaryl-4,5-dihydropyrazole, 25 | 1-[(4R)-4-[3-...)
Affinity DataIC50:  3.04E+3nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24104(1-[(5R,6R)-5-[3-(4-acetylpiperazin-1-yl)propyl]-12...)
Affinity DataIC50:  1.00E+4nMpH: 7.4 T: 2°CAssay Description:The hERG IC50 values were determined by radioligand competition experiments using membrane preparations from human embryonic kidney cells that stably...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24223(2-{4-[2-(piperidin-1-yl)ethyl]phenoxy}-1,3-benzoth...)
Affinity DataIC50:  2.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were assessed for their ability to displace [3H]astemizole using membranes from HEK-293 cells expressing the hERG K+ channel.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24224(1-{2-[4-(1,3-benzothiazol-2-yloxy)phenyl]ethyl}pip...)
Affinity DataIC50:  3.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were assessed for their ability to displace [3H]astemizole using membranes from HEK-293 cells expressing the hERG K+ channel.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM24203(2-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1,3-benzox...)
Affinity DataIC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were assessed for their ability to displace [3H]astemizole using membranes from HEK-293 cells expressing the hERG K+ channel.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM29960(arylpyrazole, 1)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:Binding affinity to the hERG K+ channel was measured by displacement of [35S]-radiolabeled MK499 in membranes derived from HEK 293 cells stably trans...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM29968(arylpyrazole, 13)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:Binding affinity to the hERG K+ channel was measured by displacement of [35S]-radiolabeled MK499 in membranes derived from HEK 293 cells stably trans...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Novobiotic Pharmaceuticals

US Patent
LigandPNGBDBM29970(arylpyrazole, 15)
Affinity DataIC50:  2.90E+3nMpH: 7.4 T: 2°CAssay Description:Binding affinity to the hERG K+ channel was measured by displacement of [35S]-radiolabeled MK499 in membranes derived from HEK 293 cells stably trans...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: